*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| Z09 - Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm - as a primary or secondary diagnosis code | ||
|---|---|---|
| OUTCOMES | ||
| Avg. LOS | ||
| Readmission Rate (%) | ||
| Unplanned Readmission Rate (%) | 15.44 | |
| Mortality Rate (%) | ||
| SNF Discharge Rate (%) | ||
| Home Discharge Rate (%) | ||
| PAYMENTS AND CHARGES | ||
| Total Medicare Payments | ||
| Payment Per Day | ||
| Payment Per Hospitalization | ||
| Total Medicare Charges | ||
| Avg. Charges | ||
| MARKET SIZING & INCIDENCE RATES | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations after Exclusion | ||
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 885: PSYCHOSES | DRG 189: PULMONARY EDEMA AND RESPIRATORY FAILURE | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 1,808,415 | ||||
| Total Hospitalizations with ICD Z09 - Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm | 360 | ||||
| DRG Share of Total Hospitalizations | 5.5 | ||||
| % of Total ICD Z09 - Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm in DRG | 4.81 | ||||
| Avg LOS at DRG | 6.34 | ||||
| Avg LOS with ICD Z09 - Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm | 6.54 | ||||
| Readmission Rate at DRG | 24.2 | ||||
| Readmission Rate with ICD Z09 - Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm | 32.27 | ||||
| Unplanned Readmission Rate at DRG | 16.78 | ||||
| Unplanned Readmission Rate with ICD Z09 - Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm | 24.28 | ||||
| Total Medicare payments at DRG | $21,288,214,047 | ||||
| Total Medicare payments with ICD Z09 - Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm | $4,110,319 | ||||
| Total Medicare payment per Day at DRG | $1,857 | ||||
| Total Medicare payment per Day with ICD Z09 - Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm | $1,745 | ||||
| Total Medicare payment per Hospitalization at DRG | $11,772 | ||||
| Total Medicare payment per Hospitalization with ICD Z09 - Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm | $11,418 | ||||
| Total Medicare Charges at DRG | $107,155,481,388 | ||||
| Total Medicare Charges with ICD Z09 - Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm | $20,399,831 | ||||
| Avg Charges at DRG | $59,254 | ||||
| Avg Charges with ICD Z09 - Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm | $56,666 | ||||
| Mortality Rate at DRG | 12.11 | ||||
| Mortality Rate with ICD Z09 - Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm | 6.11 | ||||
| SNF Discharge Rate at DRG | 27.18 | ||||
| SNF Discharge Rate with ICD Z09 - Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm | 30.28 | ||||
| Home Discharge Rate at DRG | 25.81 | ||||
| Home Discharge Rate with ICD Z09 - Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm | 26.67 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 292: HEART FAILURE AND SHOCK WITH COMPLICATION OR COMORBIDITY (CC) | DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 190: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 378: G.I. HEMORRHAGE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 194: SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 422,757 | ||||
| Total Hospitalizations with ICD Z09 - Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm | 120 | ||||
| DRG Share of Total Hospitalizations | 1.29 | ||||
| % of Total ICD Z09 - Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm in DRG | 1.6 | ||||
| Avg LOS at DRG | 4.14 | ||||
| Avg LOS with ICD Z09 - Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm | 4.22 | ||||
| Readmission Rate at DRG | 24.43 | ||||
| Readmission Rate with ICD Z09 - Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm | 28.18 | ||||
| Unplanned Readmission Rate at DRG | 18.48 | ||||
| Unplanned Readmission Rate with ICD Z09 - Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm | 21.82 | ||||
| Total Medicare payments at DRG | $2,636,135,714 | ||||
| Total Medicare payments with ICD Z09 - Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm | $717,473 | ||||
| Total Medicare payment per Day at DRG | $1,507 | ||||
| Total Medicare payment per Day with ICD Z09 - Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm | $1,415 | ||||
| Total Medicare payment per Hospitalization at DRG | $6,236 | ||||
| Total Medicare payment per Hospitalization with ICD Z09 - Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm | $5,979 | ||||
| Total Medicare Charges at DRG | $11,980,955,733 | ||||
| Total Medicare Charges with ICD Z09 - Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm | $3,297,710 | ||||
| Avg Charges at DRG | $28,340 | ||||
| Avg Charges with ICD Z09 - Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm | $27,481 | ||||
| Mortality Rate at DRG | 1.01 | ||||
| Mortality Rate with ICD Z09 - Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm | NA | ||||
| SNF Discharge Rate at DRG | 16.05 | ||||
| SNF Discharge Rate with ICD Z09 - Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm | 20.83 | ||||
| Home Discharge Rate at DRG | 47.18 | ||||
| Home Discharge Rate with ICD Z09 - Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm | 45.0 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 603: CELLULITIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 191: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH COMPLICATION OR COMORBIDITY (CC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 499,133 | ||||
| Total Hospitalizations with ICD Z09 - Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm | 111 | ||||
| DRG Share of Total Hospitalizations | 1.52 | ||||
| % of Total ICD Z09 - Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm in DRG | 1.48 | ||||
| Avg LOS at DRG | 4.34 | ||||
| Avg LOS with ICD Z09 - Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm | 4.92 | ||||
| Readmission Rate at DRG | 17.57 | ||||
| Readmission Rate with ICD Z09 - Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm | 20.79 | ||||
| Unplanned Readmission Rate at DRG | 12.56 | ||||
| Unplanned Readmission Rate with ICD Z09 - Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm | 13.86 | ||||
| Total Medicare payments at DRG | $3,254,711,780 | ||||
| Total Medicare payments with ICD Z09 - Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm | $699,707 | ||||
| Total Medicare payment per Day at DRG | $1,504 | ||||
| Total Medicare payment per Day with ICD Z09 - Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm | $1,282 | ||||
| Total Medicare payment per Hospitalization at DRG | $6,521 | ||||
| Total Medicare payment per Hospitalization with ICD Z09 - Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm | $6,304 | ||||
| Total Medicare Charges at DRG | $16,863,396,143 | ||||
| Total Medicare Charges with ICD Z09 - Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm | $4,557,390 | ||||
| Avg Charges at DRG | $33,785 | ||||
| Avg Charges with ICD Z09 - Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm | $41,058 | ||||
| Mortality Rate at DRG | 1.33 | ||||
| Mortality Rate with ICD Z09 - Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm | NA | ||||
| SNF Discharge Rate at DRG | 19.89 | ||||
| SNF Discharge Rate with ICD Z09 - Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm | 18.02 | ||||
| Home Discharge Rate at DRG | 49.27 | ||||
| Home Discharge Rate with ICD Z09 - Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm | 52.25 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 309: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 065: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH COMPLICATION OR COMORBIDITY (CC) OR TPA IN 24 HOURS | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 522,791 | ||||
| Total Hospitalizations with ICD Z09 - Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm | 88 | ||||
| DRG Share of Total Hospitalizations | 1.59 | ||||
| % of Total ICD Z09 - Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm in DRG | 1.18 | ||||
| Avg LOS at DRG | 3.14 | ||||
| Avg LOS with ICD Z09 - Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm | 3.43 | ||||
| Readmission Rate at DRG | 17.1 | ||||
| Readmission Rate with ICD Z09 - Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm | 20.48 | ||||
| Unplanned Readmission Rate at DRG | 12.62 | ||||
| Unplanned Readmission Rate with ICD Z09 - Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm | 18.07 | ||||
| Total Medicare payments at DRG | $2,290,151,156 | ||||
| Total Medicare payments with ICD Z09 - Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm | $451,729 | ||||
| Total Medicare payment per Day at DRG | $1,394 | ||||
| Total Medicare payment per Day with ICD Z09 - Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm | $1,496 | ||||
| Total Medicare payment per Hospitalization at DRG | $4,381 | ||||
| Total Medicare payment per Hospitalization with ICD Z09 - Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm | $5,133 | ||||
| Total Medicare Charges at DRG | $13,619,287,561 | ||||
| Total Medicare Charges with ICD Z09 - Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm | $2,491,025 | ||||
| Avg Charges at DRG | $26,051 | ||||
| Avg Charges with ICD Z09 - Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm | $28,307 | ||||
| Mortality Rate at DRG | 0.18 | ||||
| Mortality Rate with ICD Z09 - Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm | NA | ||||
| SNF Discharge Rate at DRG | 8.57 | ||||
| SNF Discharge Rate with ICD Z09 - Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm | 15.91 | ||||
| Home Discharge Rate at DRG | 72.49 | ||||
| Home Discharge Rate with ICD Z09 - Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm | 65.91 |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| HALIFAX REGIONAL MEDICAL CENTER | 250 SMITH CHURCH RD | ROANOKE RAPIDS | NC | 27870 | 328 |
| AURORA ST. LUKE'S MEDICAL CENTER | 2900 W OKLAHOMA AVE | MILWAUKEE | WI | 53215 | 312 |
| MEMORIAL HOSPITAL BELLEVILLE | 4500 MEMORIAL DR | BELLEVILLE | IL | 62226 | 228 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. RICHARD PHILLIP HOLM | 244 SMITH CHURCH RD | ROANOKE RAPIDS | NC | 27870 | 39 |
| Dr. KARA J QUAN | 125 E BROAD ST | ELYRIA | OH | 44035 | 25 |
| Dr. JAMES A KETOFF | 97 HIGHWAY 125 | ROANOKE RAPIDS | NC | 27870 | 23 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. TARA M STATON | 2609 MEDICAL OFFICE PL | GOLDSBORO | NC | 27534 | 49 |
| Dr. RICHARD PHILLIP HOLM | 244 SMITH CHURCH RD | ROANOKE RAPIDS | NC | 27870 | 38 |
| Dr. SATYEN VIRCHANDBHAI PATEL | 4550 MEMORIAL DR | BELLEVILLE | IL | 62226 | 35 |